Long-term outcomes in patients presenting with optic neuritis: Analyses of the MSBase registry

Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis

(2019) J. William L. Brown et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The MSBase registry: Informing clinical practice

(2019) Tomas Kalincik et al.   Multiple Sclerosis Journal

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

(2018) Alan J Thompson et al.   LANCET NEUROLOGY

Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis

(2017) Laura J Balcer et al.   Multiple Sclerosis Journal

Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis

(2017) Laura J Balcer et al.   Multiple Sclerosis Journal

20/40 or Better Visual Acuity After Optic Neuritis

(2016) Sakinah B. Sabadia et al.   JOURNAL OF NEURO-OPHTHALMOLOGY

MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines

(2016) Massimo Filippi et al.   LANCET NEUROLOGY

Data quality evaluation for observational multiple sclerosis registries

(2016) Tomas Kalincik et al.   Multiple Sclerosis Journal

Data quality evaluation for observational multiple sclerosis registries

(2016) Tomas Kalincik et al.   Multiple Sclerosis Journal

The effect of disease-modifying therapies on brain atrophy in patients with clinically isolated syndrome: a systematic review and meta-analysis

(2015) Georgios Tsivgoulis et al.   Therapeutic Advances in Neurological Disorders

Visual Function 15 Years after Optic Neuritis

(2007)   OPHTHALMOLOGY